Pharmacy Website
Clinic Website

Intelligence » HPV » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

New 'epigenetics-based' cervical cancer test outperforms Pap smear and HPV tests

Monday, December 17, 2018 -- A new test for cervical cancer was found to detect all of the cancers in a randomized clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus test at a reduced cost, according to a study led by Queen Mary University of London.

At-home HPV test effective tool for underscreened women

Wednesday, December 12, 2018 -- Nearly 80% of women from the Appalachian area of Ohio returned a mail-based HPV test, indicating that it may be a powerful resource to reach the underscreened population, according to research published in Sexually Transmitted Diseases.In the United States, HPV is the most common STD, with about one in four individuals infected, and each year, approximately 14 million Americans contract the virus, according to the CDC.“HPV self-testing is an emerging cervical cancer screening strategy, yet few mail-based HPV self-testing programs have been implemented in the United States,” Paul

[Articles] Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis

Monday, December 17, 2018 -- A large proportion of penile cancers and penile intraepithelial neoplasias are associated with infection with HPV DNA (predominantly HPV16), emphasising the possible benefits of HPV vaccination in men and boys.